Adarza News

Adarza News2018-05-02T03:18:37-05:00

St. Louis biotech startup raises $25M as it prepares for commercialization

Adarza BioSystems said the funding will help it prepare for commercialization of its ZIVA platform, a biological testing device designed to assist researchers with disease profiling and drug development.

February 6th, 2020|

Adarza raises $25 million, moves toward commercialization

Adarza, based in Maryland Heights, makes diagnostic systems for researchers and drug companies. It plans to launch its testing platform commercially in June.

February 5th, 2020|

Adarza BioSystems Raises $25 Million in Series D Funding to Launch Platform for Research and Drug Development

Biotech company Adarza BioSystems announced today that it has raised $25 million in a Series D round co-led by 3x5 Partners, based in Portland, Ore., and St. Louis-based Lightchain Capital, LLC, the family office of Scottrade founder Rodger Riney. Adarza plans to use the funds to support full commercialization of ZIVA, its automated biological testing platform for academic and clinical research. Scheduled for commercial launch in June, the ZIVA platform will allow researchers to quickly identify inflammation, cardiovascular, and oncology protein biomarkers for disease profiling and drug development.

February 4th, 2020|

Adarza BioSystems to reveal ZIVA platform at AAI 2019

Adarza Biosystems, Inc. announced today that it will reveal its new protein multiplex instrument ZIVA at Immunology 2019, the annual meeting of the American Association of Immunologists (AAI) from May 9 - 13. Using a simple, time-saving workflow, the new automated system can simultaneously measure, analyze and report on up to 200 biomarkers.

May 1st, 2019|

St. Louis Business Journal: St. Louis biotech startup to launch products in 2019

Once Adarza's products launch in the second quarter of 2019, it will be one of a handful of local life sciences startups to have done so.

May 23rd, 2018|

Adarza Sets Stage for Commercialization

Adarza Biosystems, Inc., a biotechnology company developing a novel protein and biomolecule detection platform, announced today that it has put in place the leadership, new manufacturing center and branding to begin selling its technology to researchers in the second quarter of 2019.

May 23rd, 2018|

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

RiverVest leads $17 million investment in Adarza, brings on new president

January 24th, 2017|

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization of Adarza’s first immunoassay product consumable and instrument platform. Adarza develops and manufactures immunoassay technology that can identify proteins and genetic markers in medical samples such as blood. The technology, which comes in the form of microchips, helps with cancer diagnostics [...]

January 19th, 2017|

Event Update

  Join us at the 15th Cytokines & Inflammation Conference, February 6-7, 2017 in San Diego, CA. Booth #6. And check our poster while you’re there: “A Multiplex Panel for Simultaneously Profiling Toxicant Levels and Biological Response Indicators in Serum Samples”.

January 16th, 2017|

Senior QC Manager

Adarza BioSystems, Inc. is a venture capital backed biotechnology company developing label-free protein microarray assays based on the Company’s proprietary Arrayed Imaging Reflectometry (AIR™) platform.  Adarza is seeking a Quality Manager to implement our QMS and lead the ISO 9001:2015 certification process.  Reporting to the Head of Missouri Operations, this individual will have an opportunity to develop and grow with a dynamic, emerging company in the greater St. Louis, MO area. Job Description: The position requires proven expertise in creating and maintaining a Quality Management system, starting with the Quality Policy and then translating this to a compete [...]

September 6th, 2016|

Adarza BioSystems Completes $5 M Series-B Closing

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable and instrument platform. Proceeds will also be used to accelerate development of highly sensitive assays targeting a variety of biological analytes including cytokines, antigens and small molecules. Adarza’s Arrayed Imaging Reflectometry (AIRstrip™) will bring an unprecedented combination of performance, workflow benefits with high [...]

March 24th, 2016|

Adarza BioSystems Selects SunEdison Semiconductor Site for Manufacturing Immunoassay Consumables

Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.

October 24th, 2014|

Adarza BioSystems Completes $6.8M Series-A Financing

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate development of higher plex highly sensitive assays targeting a variety of biological analytes. Adarza’s Arrayed Imaging Reflectometry (AIR-StripTM) will bring an unprecedented combination of performance and workflow benefits with high sensitivity, broad dynamic range, precision and assay robustness to life science research, drug [...]

October 1st, 2014|

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program

NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO:  The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds program. MTC made a $200,000 investment in Adaraza BioSystems, Inc, a life science technology company that has developed a disruptive biosensing technology applicable in a wide range of industries including medical diagnostics, life science tools, agriculture, and environmental testing. The startup company will primarily use funds to develop their first commercial products and hire key personnel in St. Louis. The Missouri Technology Corporation, [...]

June 27th, 2012|